Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial.
Diletti R, den Dekker WK, Bennett J, Schotborgh CE, van der Schaaf R, Sabaté M, Moreno R, Ameloot K, van Bommel R, Forlani D, van Reet B, Esposito G, Dirksen MT, Ruifrok WPT, Everaert BRC, Van Mieghem C, Elscot JJ, Cummins P, Lenzen M, Brugaletta S, Boersma E, Van Mieghem NM; BIOVASC Investigators. Diletti R, et al. Among authors: everaert brc. Lancet. 2023 Apr 8;401(10383):1172-1182. doi: 10.1016/S0140-6736(23)00351-3. Epub 2023 Mar 5. Lancet. 2023. PMID: 36889333 Clinical Trial.
Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: a recommendation from experienced users : A position statement on the use of bioresorbable vascular scaffolds in the Netherlands.
Everaert B, Felix C, Koolen J, den Heijer P, Henriques J, Wykrzykowska J, van der Schaaf R, de Smet B, Hofma S, Diletti R, Van Mieghem N, Regar E, Smits P, van Geuns RJ. Everaert B, et al. Neth Heart J. 2015 Mar;23(3):161-5. doi: 10.1007/s12471-015-0651-3. Neth Heart J. 2015. PMID: 25626696 Free PMC article.
Are BVS suitable for ACS patients? Support from a large single center real live registry.
Felix CM, Onuma Y, Fam JM, Diletti R, Ishibashi Y, Karanasos A, Everaert BRC, van Mieghem NMDA, Daemen J, de Jaegere PPT, Zijlstra F, Regar ES, van Geuns RJM. Felix CM, et al. Among authors: everaert brc. Int J Cardiol. 2016 Sep 1;218:89-97. doi: 10.1016/j.ijcard.2016.05.037. Epub 2016 May 13. Int J Cardiol. 2016. PMID: 27232918 Free article.
Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry.
Felix CM, Fam JM, Diletti R, Ishibashi Y, Karanasos A, Everaert BR, van Mieghem NM, Daemen J, de Jaegere PP, Zijlstra F, Regar ES, Onuma Y, van Geuns RJ. Felix CM, et al. JACC Cardiovasc Interv. 2016 Aug 22;9(16):1652-63. doi: 10.1016/j.jcin.2016.04.035. Epub 2016 Jul 27. JACC Cardiovasc Interv. 2016. PMID: 27476094 Free article.
Timing of Complete Multivessel Revascularization in Patients Presenting With Non-ST-Segment Elevation Acute Coronary Syndrome.
Elscot JJ, Kakar H, Scarparo P, den Dekker WK, Bennett J, Schotborgh CE, van der Schaaf R, Sabaté M, Moreno R, Ameloot K, van Bommel RJ, Forlani D, Van Reet B, Esposito G, Dirksen MT, Ruifrok WPT, Everaert BRC, Van Mieghem C, Pinar E, Alfonso F, Cummins P, Lenzen M, Brugaletta S, Daemen J, Boersma E, Van Mieghem NM, Diletti R; BIOVASC Investigators. Elscot JJ, et al. Among authors: everaert brc. JACC Cardiovasc Interv. 2024 Mar 25;17(6):771-782. doi: 10.1016/j.jcin.2024.01.278. JACC Cardiovasc Interv. 2024. PMID: 38538172 Free article. Clinical Trial.
Treatment of bioresorbable scaffold failure.
Felix C, Everaert B, Jepson N, Tamburino C, van Geuns RJ. Felix C, et al. EuroIntervention. 2015;11 Suppl V:V175-80. doi: 10.4244/EIJV11SVA42. EuroIntervention. 2015. PMID: 25983160 Free article. Review.
13 results